News
Today, we've recommended capivasertib (also called Truqap and made by AstraZeneca) with fulvestrant as an option for around 1,100 adults with hormone receptor (HR)-positive HER2-negative breast cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback